Company intelligence / Profile preview

Yili

Qingdao City, Shandong Province, Chinayili.com ↗

Ownership: Private
Development stage: Commercial

Overview

YILI Biotechnology Co.,Ltd ("YILI Bio") was founded in 2024 in Qingdao, Shandong Province, China. The company positions itself as a provider of life and health solutions with a team averaging 15 years of R&D and production experience. No specific clinical results or product pipeline details are disclosed publicly yet[1][4].

Industry: Biotech

Drug pipeline

2 assets

lacticaseibacillus paracasei K56

Preclinical

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Yili.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yili.

Explore the full profile